How Much Does Dupixent Cost? Pricing With and Without Insurance

The cost of Dupixent is one of the highest among biologic medications, reflecting its status as a breakthrough treatment for several chronic inflammatory conditions. Without insurance, the cost of Dupixent runs approximately $3,500 to $3,800 or more per month, or roughly $42,000 to $46,000 per year, at the standard adult dose. However, most patients pay significantly less through insurance and manufacturer assistance programs. List prices change over time, so treat every figure in this guide as an estimate and verify the current numbers with your pharmacy, insurer, or the manufacturer. (Free Market Healthcare is not affiliated with, and is not compensated by, Sanofi or Regeneron.)

Dupixent (dupilumab) is an FDA-approved injectable biologic manufactured by Sanofi and Regeneron. It works by blocking interleukin-4 (IL-4) and interleukin-13 (IL-13), two key proteins that drive type 2 inflammation. Dupixent is approved for a growing list of conditions, including moderate-to-severe atopic dermatitis (eczema), moderate-to-severe asthma with an eosinophilic or oral-steroid-dependent phenotype, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, and — added in 2024 — certain patients with chronic obstructive pulmonary disease (COPD) with an eosinophilic phenotype. Dupixent is prescriber-directed and dispensed by prescription only; a clinician determines whether it is appropriate for you. For a broader overview of healthcare expenses, visit our costs guide.

Dupixent Cost Without Insurance

The wholesale acquisition cost (WAC), or list price, of Dupixent places it among the more expensive biologic therapies on the market. Here is what patients can generally expect to pay without insurance (estimates vary by pharmacy and dose; verify current pricing):

• Loading dose (first injection, 600 mg): approximately $3,500 to $4,500 (two 300 mg pre-filled syringes or pens)
• Maintenance dose (300 mg every two weeks): roughly $1,750 to $2,250 per injection
• Monthly cost (two injections): about $3,500 to $3,800
• Annual cost: approximately $42,000 to $46,000

For pediatric patients aged 6 months to 5 years, dosing is weight-based and may be every four weeks at lower doses, which can reduce the monthly cost somewhat. Patients aged 6 to 17 may receive either 200 mg or 300 mg every two weeks depending on weight. Your prescriber and specialty pharmacy will confirm the exact regimen and cost for your situation.

Dupixent Cost With Insurance

Most commercial insurance plans and Medicare cover Dupixent for approved indications, though the level of coverage varies. Dupixent is typically placed on the specialty tier of insurance formularies, which often requires higher co-pays or coinsurance.

Typical insurance costs (estimates; confirm with your plan):

• Commercial insurance with specialty co-pay: $50 to $300 per month, depending on the plan
• Commercial insurance with coinsurance: 20–30% coinsurance can mean $600 to $1,000+ per month before reaching your out-of-pocket maximum
• Medicare Part D: Costs vary by plan. Thanks to the Inflation Reduction Act, annual out-of-pocket Part D spending is capped at $2,000 (beginning in 2025 and indexed thereafter), which meaningfully limits what Medicare patients pay for high-cost drugs like Dupixent over a year
• Medicaid: Typically covered with minimal to no co-pay after prior authorization

Common prior authorization requirements:

• Documented diagnosis of the approved condition (atopic dermatitis, asthma, nasal polyps, EoE, prurigo nodularis, COPD, etc.)
• Failure of first-line therapies (topical corticosteroids, immunosuppressants, or inhaled corticosteroids depending on the condition)
• Documentation of disease severity using validated scoring tools
• Periodic reauthorization every 6 to 12 months

Dupixent Savings Programs and Patient Assistance

Sanofi and Regeneron offer patient support programs, delivered through Dupixent MyWay, to help offset the cost of Dupixent. You can reach the program at 1-844-DUPIXENT (1-844-387-4936). Details and eligibility can change, so confirm current terms directly.

Dupixent MyWay Copay Card (commercially insured patients):

• Eligible patients may pay as little as $0 per fill of Dupixent
• Subject to an annual program maximum per patient per calendar year
• Available to patients with commercial/private insurance, including plans purchased on the exchanges and many federal or state employee plans
• Not valid for patients with Medicare, Medicaid, VA, DoD, TRICARE, or other government insurance
• Enrollment is available online, by phone, or through your prescribing physician

Dupixent MyWay Patient Assistance Program (uninsured or underinsured patients):

• May provide Dupixent at no cost to eligible patients, evaluated case by case
• Income-based eligibility requirements apply
• Open to uninsured patients, those experiencing payment difficulties, and some Medicare Part D enrollees
• Requires an application with prescriber documentation

Additional cost-reduction options:

• Independent co-pay assistance foundations such as the PAN Foundation and the HealthWell Foundation (helpful for patients on Medicare, who cannot use the manufacturer copay card)
• State pharmaceutical assistance programs
• Specialty pharmacy negotiated pricing
• Hospital and health-system financial assistance programs

Dupixent Cost by Condition

While the per-dose cost of Dupixent is the same regardless of the condition being treated, dosing frequency and duration can affect total costs:

• Atopic dermatitis (adults): 300 mg every two weeks, ongoing. Annual cost approximately $42,000 to $46,000 at retail.
• Asthma: 200 mg or 300 mg every two weeks (depending on whether oral-corticosteroid-dependent), ongoing. Similar price range to atopic dermatitis dosing.
• Chronic rhinosinusitis with nasal polyps: 300 mg every two weeks, ongoing. Same pricing as other indications.
• Eosinophilic esophagitis: weight-based dosing that for many adults is 300 mg weekly, which can roughly double the monthly cost to approximately $7,000 to $7,600 at retail without insurance.
• Prurigo nodularis: 300 mg every two weeks after a loading dose. Standard pricing applies.
• COPD (eosinophilic phenotype): 300 mg every two weeks, added on to background inhaled therapy. Standard pricing applies.

If you are managing eczema and exploring telehealth options for ongoing care, our guide on best telehealth for eczema reviews platforms that can help coordinate your treatment.

Is There a Generic or Biosimilar Version of Dupixent?

As of 2026, there is no generic or biosimilar version of Dupixent available in the United States. Because Dupixent is a biologic medication, future lower-cost alternatives would take the form of biosimilars rather than traditional small-molecule generics. Sanofi and Regeneron hold patent protections expected to extend into at least the late 2020s to early 2030s. You can confirm whether any dupilumab biosimilar has been approved by checking the FDA’s Purple Book database, the official record of licensed biologics and biosimilars.

When biosimilars do eventually enter the market, they are commonly priced below the branded product — analysts often estimate discounts in the range of 15% to 35%, though real-world biosimilar savings vary widely. For now, the savings programs described above remain the most effective way to manage costs, and prices should be verified against current sources.

Is Dupixent Worth the Cost?

The clinical evidence supporting Dupixent is strong across its approved indications. Illustrative findings from pivotal trials include:

• Atopic dermatitis: In the SOLO 1 and SOLO 2 trials, roughly 36–38% of patients achieved clear or almost-clear skin at 16 weeks, compared with about 8–10% with placebo (published in the New England Journal of Medicine).
• Asthma: The LIBERTY ASTHMA QUEST trial showed a substantial reduction in severe asthma exacerbations and improvement in lung function.
• Nasal polyps: The SINUS-24 and SINUS-52 trials demonstrated significant reductions in polyp size and improvements in congestion, sense of smell, and sinus symptoms.
• Eosinophilic esophagitis: FDA-approved in 2022, with trials showing meaningful histological and symptomatic improvement.
• COPD: FDA-approved in 2024 for patients with an eosinophilic phenotype, based on trials showing fewer moderate-to-severe exacerbations.

For patients with moderate-to-severe disease who have not responded adequately to conventional treatments, Dupixent can dramatically improve quality of life. Cost-effectiveness varies by indication and disease severity, but many analyses consider it reasonable value for patients with severe disease and limited alternatives. Whether it is right for you is a clinical decision to make with your prescriber.

Frequently Asked Questions

How long do I need to take Dupixent?

Dupixent is typically prescribed as an ongoing, long-term treatment. The conditions it treats are chronic, and symptoms generally return when the medication is discontinued. Your physician may periodically reassess whether continued treatment is necessary, but many patients remain on Dupixent long-term if it is effective and well-tolerated.

Can I get Dupixent through a specialty pharmacy?

Yes, Dupixent is almost always dispensed through specialty pharmacies rather than retail pharmacies. These pharmacies provide additional services such as insurance navigation, prior authorization support, and home delivery. Your prescribing physician typically coordinates with a specialty pharmacy to facilitate your prescription.

What if my insurance denies Dupixent?

If your insurance denies coverage, your physician can submit an appeal with additional clinical documentation supporting medical necessity. The Dupixent MyWay program can also assist with the appeals process. If a denial is upheld, the patient assistance program may provide the medication at no cost based on income eligibility.

Are there cheaper alternatives to Dupixent for eczema?

For atopic dermatitis, alternatives include topical treatments (corticosteroids, calcineurin inhibitors, and PDE4 inhibitors such as crisaborole), systemic immunosuppressants (methotrexate, cyclosporine, mycophenolate), and other biologics or JAK inhibitors (such as tralokinumab/Adbry, and the oral JAK inhibitors Rinvoq and Cibinqo). Some of these may be less expensive, though their safety and efficacy profiles differ and JAK inhibitors carry their own boxed warnings. Your dermatologist can help determine the best option based on your disease severity, medical history, and insurance coverage.

Does Medicare cover Dupixent?

Medicare Part D plans generally cover Dupixent, though costs vary by plan and it usually requires prior authorization. Medicare patients cannot use the manufacturer copay card, but the Inflation Reduction Act’s $2,000 annual out-of-pocket cap on Part D drug spending limits total yearly costs, and independent foundations may offer additional help. Verify your specific plan’s coverage.

Final Thoughts on the Cost of Dupixent

The cost of Dupixent at retail price is substantial, but the majority of patients do not pay full price. The Dupixent MyWay copay card can reduce out-of-pocket costs to as little as $0 per fill for eligible commercially insured patients, and the patient assistance program may provide the medication at no cost for eligible uninsured patients. If you are considering Dupixent, work closely with your prescribing physician and the Dupixent MyWay support team to navigate insurance requirements and maximize your savings opportunities. The investment in proper treatment for chronic inflammatory conditions can yield significant improvements in quality of life, productivity, and long-term health — but always confirm current pricing and program terms, which change over time.

Sources

• Dupixent MyWay — official copay card and patient assistance program (dupixent.com)
• Sanofi / Regeneron — Dupixent indications and prescribing information (dupixent.com)
• FDA — Dupixent approvals and Purple Book biosimilar database (fda.gov)
• MedlinePlus — Dupilumab (medlineplus.gov)